Sellahewa, R., Lundy, J., Croagh, D., & Jenkins, B. (2021). High circulating tumour DNA is a strong negative prognostic factor in operable pancreatic cancer. HPB (1365-182X), 23, S263. https://doi.org/10.1016/j.hpb.2020.11.664
Chicago Style (17th ed.) CitationSellahewa, R., J. Lundy, D. Croagh, and B. Jenkins. "High Circulating Tumour DNA Is a Strong Negative Prognostic Factor in Operable Pancreatic Cancer." HPB (1365-182X) 23 (2021): S263. https://doi.org/10.1016/j.hpb.2020.11.664.
MLA (9th ed.) CitationSellahewa, R., et al. "High Circulating Tumour DNA Is a Strong Negative Prognostic Factor in Operable Pancreatic Cancer." HPB (1365-182X), vol. 23, 2021, p. S263, https://doi.org/10.1016/j.hpb.2020.11.664.
Warning: These citations may not always be 100% accurate.